Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?

NCT06078891 is registered in ClinicalTrials.gov with Tamir Ben-Hur as lead sponsor.

NCT NCT06078891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06078891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?
Lead sponsor
Tamir Ben-Hur
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
July 1, 2023
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, late onset